[go: up one dir, main page]

AU2001238493A1 - Methods and compositions for the identification, assessment, prevention and therapy of human cancers - Google Patents

Methods and compositions for the identification, assessment, prevention and therapy of human cancers

Info

Publication number
AU2001238493A1
AU2001238493A1 AU2001238493A AU3849301A AU2001238493A1 AU 2001238493 A1 AU2001238493 A1 AU 2001238493A1 AU 2001238493 A AU2001238493 A AU 2001238493A AU 3849301 A AU3849301 A AU 3849301A AU 2001238493 A1 AU2001238493 A1 AU 2001238493A1
Authority
AU
Australia
Prior art keywords
assessment
therapy
prevention
compositions
identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001238493A
Inventor
Frederick P. Roth
Andrew W. Shyjan
Christophe Van Huffel
James V. White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
MILLENNIUM PREDICTIVE MEDICINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MILLENNIUM PREDICTIVE MEDICINE filed Critical MILLENNIUM PREDICTIVE MEDICINE
Publication of AU2001238493A1 publication Critical patent/AU2001238493A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G01N33/575
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001238493A 2000-02-17 2001-02-16 Methods and compositions for the identification, assessment, prevention and therapy of human cancers Abandoned AU2001238493A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18331200P 2000-02-17 2000-02-17
US60/183,312 2000-02-17
PCT/US2001/005263 WO2001061048A2 (en) 2000-02-17 2001-02-16 Methods and compositions for the identification, assessment, prevention and therapy of human cancers

Publications (1)

Publication Number Publication Date
AU2001238493A1 true AU2001238493A1 (en) 2001-08-27

Family

ID=22672288

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001238493A Abandoned AU2001238493A1 (en) 2000-02-17 2001-02-16 Methods and compositions for the identification, assessment, prevention and therapy of human cancers

Country Status (3)

Country Link
US (1) US20020051978A1 (en)
AU (1) AU2001238493A1 (en)
WO (1) WO2001061048A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070166704A1 (en) * 2002-01-18 2007-07-19 Fei Huang Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways
CN102989009B (en) * 2003-12-31 2015-06-03 宾夕法尼亚州研究基金会 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence
US7183257B2 (en) * 2004-04-14 2007-02-27 The Brigham And Women's Hospital, Inc. Use of RPL41 to treat infections and inhibit cancer
US20060121511A1 (en) * 2004-11-30 2006-06-08 Hyerim Lee Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
BRPI0518884A2 (en) * 2004-12-08 2008-12-30 Aventis Pharma Inc Method for measuring resistance or sensitivity to docetaxel
CA2596469A1 (en) * 2005-02-01 2006-08-10 Government Of The U.S.A, As Represented By The Secretary Department Of H Ealth & Human Services Biomarkers for tissue status
US20070218487A1 (en) * 2006-03-03 2007-09-20 University Of Southern California Genetic markers for predicting disease and treatment outcome
WO2008011046A2 (en) * 2006-07-17 2008-01-24 The H.Lee Moffitt Cancer And Research Institute, Inc. Computer systems and methods for selecting subjects for clinical trials
EP2115163A2 (en) * 2007-01-18 2009-11-11 University Of Southern California Gene polymorphisms as sex-specific predictors in cancer therapy
WO2008115561A2 (en) * 2007-03-21 2008-09-25 Bristol-Myers Squibb Company Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
JP5606438B2 (en) * 2008-07-23 2014-10-15 エフ.ホフマン−ラ ロシュ アーゲー Identification of subjects who can receive anti-angiogenic therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736326A (en) * 1987-05-05 1998-04-07 City Of Hope Method of detecting resistance to chemo therapeutic agents in cancer patients

Also Published As

Publication number Publication date
WO2001061048A2 (en) 2001-08-23
US20020051978A1 (en) 2002-05-02
WO2001061048A3 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
AU2002322280A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2001236519A1 (en) Identification, assessment, prevention, and therapy of prostate cancer
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2001251613A1 (en) Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002219782A1 (en) Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001245295A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU7701100A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
IL158206A0 (en) Compositions and methods for the prevention and treatment of human prostate cancer
AU2002257033A1 (en) Agents and methods for the prevention of initial onset and recurrence of existing cancers
AU2001238493A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
AU2074101A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
AU2596901A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002241720A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer